Site Selection

Facility Planning

Workforce Development

Business+Place

AD Editorial Board

Aaron Ahlburn

Managing Director and Senior Director, Research, JLL
Amy Gerber

Executive Managing Director, Business Incentives Practice, Cushman & Wakefield
Bill Luttrell

Senior Locations Strategist, Werner Global Logistics, Werner Enterprises
Bradley Migdal

Senior Managing Director, Business Incentives Practice, Cushman & Wakefield, Inc.
Brian Corde

Managing Partner, Atlas Insight
Dan Levine

Practice Leader, Location Strategies and Economic Development, Oxford Economics, Inc.
Dan White

Senior Economist, Moody's Analytics
Dean J. Uminski, CEcD

Partner, Crowe Horwath
Dennis Cuneo

Partner , Fisher & Phillips
Eric Stavriotis

Senior Vice President, Advisory & Transaction Services, CBRE, Inc.
Gregory Burkart

Managing Director and City Leader, Site Selection & Incentives Advisory , Duff & Phelps, LLC
H. Robert Boehringer, III

Managing Director, Global Location & Expansion Services, KPMG
Josh Bays

Principal, Site Selection Group, LLC
Joshua Wright

VP, Economic and Workforce Development, Emsi
Kate Crowley

Principal & Negotiated incentives Practice Leader, Baker Tilly Virchow Krause, LLP
Les Cranmer

Senior Managing Director, Savills Studley
Marc Beauchamp

President & CEO, The CAI Global Group
Margy Sweeney

Founder and CEO, Akrete, Inc.
Minah Hall

Managing Director, True Partners Consulting LLC
Paul Naumoff

Principal, National Director of Tax Credits & Incentives Advisory Services, EY Global/Americas
Scott Kupperman

Founder, Kupperman Location Solutions
Stephen Gray

CEO, Gray Construction

Novartis Builds on PEI's Strengths

Area Development Research Desk

Location Canada 2009

In 2006 Novartis opened its state-of-the-art Animal Health's Center for Aqua Research and Development facility in Victoria, Prince Edward Island. The goal of the PEI R&D facility is to bring new and innovative vaccine solutions for preventing and controlling disease-causing pathogens in farmed fish species, including salmon, carp, marine fish, tilapia, and catfish.

According to Novartis Canada CEO Grant Roberts, "By expanding our facilities, we are supporting aquaculture through continued in-depth study of health solutions for the challenges that face both currently cultured and emerging species of fish." Roberts sees a number of advantages to the company's investments in Prince Edward Island: "PEI has quality marine resources and top research institutes that make it attractive for a company like Novartis to maintain one of our five global research and development centers here," he concludes. "We look forward to continuing the great partnerships in place here."